Polomar Health Services, Inc.
PMHSOTCHealthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|
| Revenue | $648,231 | $58,824 | $41,844 | $34,526 |
| Operating income | −$10.6M | −$1.3M | −$440,832 | −$181,453 |
| Net income | −$10.7M | −$1.3M | −$587,997 | −$181,124 |
| Total assets | $390,043 | $10.0M | $107,099 | $261,484 |
| Total liabilities | $1.6M | $1.4M | $151,635 | $74,715 |
| Equity | −$1.2M | $8.6M | −$44,536 | $186,769 |
| EPS (diluted) | $-0.39 | $-0.05 | $-0.02 | $0.00 |
| Shares out. | 26.7M | 109.1M | 27.7M | 107.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −1627.5%
- Net margin
- −1650.8%
- Return on equity
- 875.5%
- Return on assets
- −2743.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 413.4%
- Debt / equity
- —
- Book value / share
- $-0.05
- Revenue growth (YoY)
- 1002.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -318.03distress
- Accruals / assets
- −2642.0%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 18, 2026
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2025
- NT 10-Qmissed a reporting deadline ↗May 16, 2025
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Jan 30, 2026 | 565 | 43.5 | 0.0% |
| Jan 15, 2026 | 565 | 282.5 | -0.5% |
| Dec 31, 2025 | 568 | 2.2 | -0.3% |
| Dec 15, 2025 | 1,140 | 1000.0 | -0.2% |
| Nov 28, 2025 | 1,142 | 42.3 | +100.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Other material eventMay 15, 2026
- Terminated a material agreementApr 29, 2026
- Entered a material agreementDec 12, 2025
- Entered a material agreementOct 14, 2025
- Entered a material agreementAug 29, 2025
- Entered a material agreementJul 29, 2025
- Entered a material agreementJul 25, 2025
- Entered a material agreementJul 24, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.